Claims for Patent: 10,052,333

Summary for Patent: 10,052,333

Title:	Methods and systems for the delivery of a therapeutic agent
Abstract:	The present invention provides a liquid pharmaceutical composition comprising a therapeutic agent and an alkoxy-polyethylene glycol, for example, methoxy-polyethylene glycol, for administration of the therapeutic agent to the mammal. The compositions can be applied to a membrane, for example, a nasal membrane during intranasal administration. The invention also provides methods of administering such compositions to a mammal.
Inventor(s):	Gizurarson; Sveinbjorn (Reykjavik, IS)
Assignee:	UNIVERSITY OF ICELAND (Reykjavik, IS)
Application Number:	15/605,709
Patent Claims:	1. A liquid pharmaceutical composition formulated for intranasal administration comprising: a) a therapeutically effective amount of a therapeutic agent, a pharmaceutically acceptable salt thereof or combinations thereof; and b) a methoxy-polyethylene glycol of Formula I H.sub.3C--O--(CH.sub.2CH.sub.2O).sub.n--H wherein n is a number in the range of from about 1 to about 25. 2. The pharmaceutical composition of claim 1, wherein the therapeutic agent is selected from the group consisting of an analgesic agent, an anti-inflammatory agent, an anti-arrhythmic agent, an anti-asthma agent, an anti-bacterial agent, an anti-viral agent, an anti-coagulant, an anti-depressant, an anti-diabetic, an anti-epileptic, an anti-fungal agent, an anti-hypertensive agent, an anti-malarial, an anti-migraine agent, an anti-muscarinic agent, an anti-neoplastic agent, an immunosuppressant, an anti-protozoal agent, an anti-thyroid agent, an anxiolytic agent, a sedative, a hypnotic agent, a neuroleptic agent, a beta-Blocker, a cardiac inotropic agent, a corticosteroid, a diuretic agent, an anti-Parkinsonian agent, a gastrointestinal agent, an anti-histamine, a histamine-receptor antagonist, a lipid regulating agent, a muscle relaxant, nitrate and other anti-anginal agent, a nutritional agent, an opioid analgesic, sex hormone, stimulant, cytokine, peptidomimetic, peptide, protein, toxoid, sera, antibody, vaccine, nucleoside, nucleotide, nucleic acid and a peptidyl-nucleic acid. 3. A method of administering a therapeutic agent to a mammal, the method comprising administering to an intranasal mucosal membrane of the mammal a liquid pharmaceutical composition comprising: a) a therapeutically effective amount of a therapeutic agent, a pharmaceutically acceptable salt thereof or combinations thereof; and b) a methoxy-polyethylene gycol of Formula I H.sub.3C--O--(CH.sub.2CH.sub.2O).sub.n--H wherein n is a number in the range of from about 1to about 25. 4. The system for intranasal delivery of a liquid pharmaceutical composition formulated for intranasal administration comprising: a) a nasal spray device; and b) a liquid pharmaceutical composition formulated for intranasal administration disposed in the nasal spray device, the liquid pharmaceutical composition comprising: i) a therapeutically effective amount of a therapeutic agent, a pharmaceutically acceptable salt thereof or combinations thereof; and ii) a methoxy-polyethylene gycol of Formula I H.sub.3C--O--(CH.sub.2CH.sub.2O).sub.n--H wherein n is a number in the range of from about 1 to about 25. 5. A system of claim 4, wherein the therapeutic agent is selected from the group consisting of an analgesic agent, an anti-inflammatory agent, an anti-arrhythmic agent, an anti-asthma agent, an anti-bacterial agent, an anti-viral agent, an anti-coagulant, an anti-depressant, an anti-diabetic, an anti-epileptic, an anti-fungal agent, an anti-hypertensive agent, an anti-malarial, an anti-migraine agent, an anti-muscarinic agent, an anti-neoplastic agent, an immunosuppressant, an anti-protozoal agent, an anti-thyroid agent, an anxiolytic agent, a sedative, a hypnotic agent, a neuroleptic agent, a beta-Blocker, a cardiac inotropic agent, a corticosteroid, a diuretic agent, an anti-Parkinsonian agent, a gastrointestinal agent, an anti-histamine, a histamine-receptor antagonist, a lipid regulating agent, a muscle relaxant, nitrate and other anti-anginal agent, a nutritional agent, an opioid analgesic, sex hormone, stimulant, cytokine, peptidomimetic, peptide, protein, toxoid, sera, antibody, vaccine, nucleoside, nucleotide, nucleic acid and a peptidyl-nucleic acid.

Details for Patent 10,052,333

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Jubilant Hollisterstier Llc	N/A	positive skin test control-histamine	Injection	103891	March 13, 1924		2037-05-25